Amiodarone/baricitinib/favipiravirHypothyroidism and off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1962卷 / 1期

关键词：

D O I：

10.1007/s40278-023-41695-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：25 / 25

相关论文

共 50 条

[11] Adenosine/amiodarone/sirolimusVarious toxicities, off-label use and lack of efficacy: case report
Reactions Weekly, 2022, 1921 (1) : 16 - 16
[12] Baricitinib/enoxaparin-sodium/methylprednisoloneRectus sheath haematoma and off-label use: case report
Reactions Weekly, 2022, 1934 (1) : 102 - 102
[13] PosaconazoleHepatotoxicity and off-label use: case report
Reactions Weekly, 2024, 2021 (1) : 447 - 447
[14] PasireotideHyperglycaemia and off-label use: case report
Reactions Weekly, 2021, 1876 (1) : 273 - 273
[15] RituximabHypogammaglobulinaemia and off-label use: case report
Reactions Weekly, 2023, 1956 (1) : 453 - 453
[16] ClozapineSyncope and off-label use: case report
Reactions Weekly, 2022, 1930 (1) : 198 - 198
[17] LinezolidLeukopenia and off-label use: case report
Reactions Weekly, 2025, 2044 (1) : 180 - 180
[18] IbrutinibNeutropenia and off-label use: case report
Reactions Weekly, 2020, 1787 (1) : 271 - 271
[19] DexmedetomidineHypotension and off-label use: case report
Reactions Weekly, 2019, 1749 (1) : 172 - 172
[20] AzithromycinCardiotoxicity and Off-label use: case report
Reactions Weekly, 2023, 1953 (1) : 100 - 100

← 1 2 3 4 5 →